Sapporo Clinical Laboratory

9776.T
Financials · Consolidated

From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 12
PeriodFormFiledFigures
2025-04-01 → 2025-09-30Half-year2025-11-1067 figures · EDINET
2024-04-01 → 2025-03-31Annual2025-06-26197 figures · EDINET
2024-04-01 → 2024-09-30Half-year2024-11-1167 figures · EDINET
2023-04-01 → 2024-03-31Annual2024-06-27197 figures · EDINET
2023-04-01 → 2023-12-31Quarterly Q32024-02-1345 figures · EDINET
2023-04-01 → 2023-09-30Quarterly Q22023-11-1369 figures · EDINET
2023-04-01 → 2023-06-30Quarterly Q12023-08-0943 figures · EDINET
2022-04-01 → 2023-03-31Annual2023-06-29197 figures · EDINET
2022-04-01 → 2022-12-31Quarterly Q32023-02-1345 figures · EDINET
2022-04-01 → 2022-09-30Quarterly Q22022-11-1169 figures · EDINET
2022-04-01 → 2022-06-30Quarterly Q12022-08-1043 figures · EDINET
2021-04-01 → 2022-03-31Annual2022-06-29197 figures · EDINET

21 more reports are still being processed.

Segments · FY ended 2025-03
SegmentExternal salesProfitAssets
Clinical Testing Business¥7.8bn¥255m¥3.5bn
Dispensing Pharmacy Business¥11.3bn¥742m¥3.4bn
Medical Devices Sales And Maintenance Business¥874m−¥4m¥701m
Other segments¥166m¥125m¥62m
Total¥20.0bn¥993m¥7.5bn
Total¥20.1bn¥1.1bn¥7.6bn

Segment names from EDINET member IDs; not mapped to a common taxonomy.